Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04223661
Title Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tyler Davis, MD, FACP
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
VA Roudebush Medical Center Indianapolis Indiana 46202 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field